PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Benzododecinium→

Benzododecinium PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
10328-35-5
Molecular formula
C21H38N+
Molecular weight
304.5 g/mol
Drug class
Quaternary ammonium cationic surfactantantiseptic and disinfectant ingredient
Mechanism of action
Interacts with microbial membranes and disrupts membrane integrity, causing leakage of intracellular constituents and microbial death. It is primarily a local antiseptic or biocidal ingredient.
Indications / reported uses
  • Topical antiseptic or disinfectant use in selected skin and mucosal preparations where authorised; not a systemic therapeutic API indication

Sources: PubChem — Benzododecinium · NLM MeSH — Quaternary ammonium antiseptics · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Benzododecinium PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Benzododecinium Permitted Daily Exposure (PDE) report (the Benzododecinium PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Benzododecinium Occupational Exposure Limit (OEL) report (the Benzododecinium OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.